$6.76
-0.78-10.34%
Last update: Nov 5, 4:39 PM
Olema Pharmaceuticals inc
OLMANASDAQ
The average analyst price target for Olema Pharmaceuticals is $40.67, 501.6% above the current price. Of 10 analysts, 10 rate it Buy. Targets range from $27 to $59. The latest change came on Sep 14, 2026, when Stifel lowered its price target on Olema Pharmaceuticals from $48 to $30 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
